4.8 Article

A single-cell multiomic analysis of kidney organoid differentiation

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.2219699120

关键词

kidney organoid; scRNA-seq; scATAC-seq; CUT & RUN; CRISPR interference

向作者/读者索取更多资源

Comparing the gene regulatory landscape between kidney organoids and adult human kidney can help evaluate the differentiation progress at the epigenome and transcriptome level. The study found that organoid cell types have more open chromatin compared to adult human kidney. Using enhancer dynamics analysis, the researchers validated an enhancer that drives transcription of HNF1B during organoid differentiation. This study provides an experimental framework to assess the cell-specific maturation state of human kidney organoids and validates gene regulatory networks involved in differentiation.
Kidney organoids differentiated from pluripotent stem cells are powerful models of kidney development and disease but are characterized by cell immaturity and off-target cell fates. Comparing the cell-specific gene regulatory landscape during organoid differentiation with human adult kidney can serve to benchmark progress in differentiation at the epigenome and transcriptome level for individual organoid cell types. Using single-cell multiome and histone modification analysis, we report more broadly open chromatin in organoid cell types compared to the human adult kidney. We infer enhancer dynamics by cis-coaccessibility analysis and validate an enhancer driving transcription of HNF1B by CRISPR interference both in cultured proximal tubule cells and also during organoid differentiation. Our approach provides an experimental framework to judge the cell-specific maturation state of human kidney organoids and shows that kidney organoids can be used to validate individual gene regulatory networks that regulate differentiation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Urology & Nephrology

Kidney repair and regeneration: perspectives of the NIDDK (Re)Building a Kidney consortium

Bilal A. Naved, Joseph Bonventre, Jeffrey A. Hubbell, Neil A. Hukriede, Benjamin D. Humphreys, Carl Kesselman, M. Todd Valerius, Andrew P. McMahon, Stuart J. Shankland, Jason A. Wertheim, Michael J. White, Mark P. de Caestecker, Iain A. Drummond

Summary: Acute kidney injury is a serious global health issue with millions of individuals affected and significant mortality rates. The (Re)Building a Kidney (RBK) consortium is focused on studying endogenous kidney repair mechanisms and generating new kidney tissue. This review provides an update on RBK studies of nephron repair and addresses important questions regarding the cellular sources and drivers of repair. Additionally, it highlights the importance of RBK in promoting the development of therapeutics and provides a guide to their open access data hub.

KIDNEY INTERNATIONAL (2022)

Article Biotechnology & Applied Microbiology

Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis

Minori Tamai, Shinichi Fujisawa, Thao T. T. Nguyen, Chiaki Komatsu, Keiko Kagami, Kenji Kamimoto, Kohei Omachi, Shin Kasai, Daisuke Harama, Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Kazuhito Naka, Tadashi Kaname, Takanori Teshima, Takeshi Inukai

Summary: The Philadelphia chromosome, generated by aberrant ligation between the BCR and ABL1 genes, is the first translocation identified in leukemia. Simultaneous double-strand breaks at the breakpoints of these genes have been found to be the initiation events for Ph+ leukemia and lead to the fusion of BCR and ABL1.

CANCER GENE THERAPY (2023)

Article Urology & Nephrology

Reimagining Nephrology Fellowship Education to Meet the Future Needs of Nephrology A Report of the American Society of Nephrology Task Force on the Future of Nephrology

Mark E. Rosenberg, Sharon Anderson, Samira S. Farouk, Keisha L. Gibson, Robert S. Hoover, Benjamin D. Humphreys, Janis M. Orlowski, Suneel M. Udani, Joshua S. Waitzman, Melissa West, Tod Ibrahim

Summary: The American Society of Nephrology (ASN) Task Force on the Future of Nephrology was established to address training requirements and improve the quality of care in nephrology. The task force developed 10 recommendations to promote equitable care, highlight the value of nephrology, and enhance nephrology education. This report reviews the process, rationale, and details of these recommendations.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Urology & Nephrology

Elucidating the Proximal Tubule HNF4A Gene Regulatory Network in Human Kidney Organoids

Yasuhiro Yoshimura, Yoshiharu Muto, Kohei Omachi, Jeffrey H. Miner, Benjamin D. Humphreys

Summary: This study reveals the regulatory mechanisms of HNF4A and HNF4G during human proximal tubule differentiation. The experimental strategy can be applied more broadly to investigate transcriptional regulation in human kidney development.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Editorial Material Urology & Nephrology

Close Encounters of the Tertiary Kind: Intercellular Inflammatory Communication Long after AKI

Benjamin D. Humphreys

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Urology & Nephrology

CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion

Jun Kuwazuru, Mary Ann Suico, Kohei Omachi, Haruka Kojima, Misato Kamura, Shota Kaseda, Teppei Kawahara, Yuki Hitora, Hikaru Kato, Sachiko Tsukamoto, Mikiyo Wada, Toshifumi Asano, Shunsuke Kotani, Makoto Nakajima, Shogo Misumi, Yuya Sannomiya, Jun Horizono, Yuimi Koyama, Aimi Owaki, Tsuyoshi Shuto, Hirofumi Kai

Summary: This study provides a novel therapeutic candidate, alisporivir, for Alport syndrome (AS) by enhancing the secretion of mutant 345(IV) and reveals the importance of cyclophilin D in this process. It suggests that alisporivir could be a safer option than cyclosporin A for AS treatment.

KIDNEY360 (2023)

Article Urology & Nephrology

PPARd Agonism Ameliorates Renal Fibrosis in an Alport Syndrome Mouse Model

Kohei Omachi, Colin O'Carroll, Jeffrey H. Miner

Summary: This study investigated the effects of PPARd agonist REN001 in a mouse model of Alport syndrome. The results showed that REN001 reduced proteinuria, decreased BUN levels, and improved renal inflammation and fibrosis. The combination of REN001 with ACEis may have additive effects to attenuate renal injury and slow disease progression.

KIDNEY360 (2023)

暂无数据